Number of consulting medical institutions and risk of polypharmacy in community-dwelling older people under a healthcare system with free access: a cross-sectional study in Japan
Open Access
- 26 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Health Services Research
- Vol. 20 (1), 1-9
- https://doi.org/10.1186/s12913-020-05205-6
Abstract
Under the Japanese free access healthcare system, patients are allowed to consult multiple medical institutions (including clinics and hospitals for general or specialist consultation) without primary care referral. This potentially increases the risk of polypharmacy. We examined the association between the number of consulting medical institutions and polypharmacy under a healthcare system with free access. Via a self-administered questionnaire, we identified people aged ≥65 years with ≥1 disease and ≥1 consulting medical institution in a Japanese city in 2016. The exposure of interest was the number of consulting medical institutions (1, 2, or ≥3) and the outcome was polypharmacy (use of ≥6 types of drugs). We performed a multivariate logistic regression analysis, adjusting for age, sex, household economy, and the number and type of comorbidities. To minimize confounding effects, we also performed propensity-score-matched analysis, categorizing patients into two groups: 1 and ≥2 consulting medical institutions. Of 993 eligible individuals (mean (standard deviation) age: 75.1 (6.5) years, men: 52.6%), 15.7% (156/993) showed polypharmacy. Proportions of polypharmacy were 9.7% (50/516), 16.6% (55/332), and 35.2% (51/145) for people who consulted 1, 2, and ≥3 medical institutions, respectively. Relative to people who consulted 1 medical institution, adjusted odds ratios (95% confidence intervals) for polypharmacy were 1.50 (0.94–2.37) and 3.34 (1.98–5.65) for those who consulted 2 and ≥3 medical institutions, respectively. In propensity score matching, of 516 and 477 patients who consulted 1 and ≥2 medical institutions, 307 pairs were generated. The proportion of polypharmacy was 10.8% (33/307) and 17.3% (53/307), respectively (P = 0.020). The odds ratio for polypharmacy (≥2 vs. 1 consulting medical institution) was 1.73 (95% confidence interval 1.09–2.76). Patients who consulted more medical institutions were more likely to show polypharmacy. The results could encourage physicians and pharmacists to collect medication information more actively and conduct appropriate medication reviews. Strengthening primary care is needed to address the polypharmacy issue, especially in countries with healthcare systems with free access.Keywords
Funding Information
- Ministry of Health, Labour and Welfare (H28-junkankitou-ippan-009 and H30-choju-ippan-007, 19AA2007)
This publication has 18 references indexed in Scilit:
- Correlation between the Barthel Index and care need levels in the Japanese long‐term care insurance systemGeriatrics & Gerontology International, 2019
- Prescription of potentially inappropriate medications to older adults. A nationwide survey at dispensing pharmacies in JapanArchives of Gerontology and Geriatrics, 2018
- Polypharmacy and Multimorbidity Among Medicaid Enrollees: A Multistate AnalysisPopulation Health Management, 2018
- Factors associated with polypharmacy in elderly home‐care patientsGeriatrics & Gerontology International, 2017
- Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic MalaysiaPLOS ONE, 2017
- Association between polypharmacy and multiple uses of medical facilities in nursing home residentsGeriatrics & Gerontology International, 2016
- Polypharmacy as a risk factor for hospital admission among ambulance‐transported old‐old patientsAcute Medicine & Surgery, 2015
- Polypharmacy and Adverse Drug Events Leading to Acute Care Hospitalization in Japanese ElderlyGeneral Medicine, 2014
- Polypharmacy and Mortality Among Nursing Home Residents With Advanced Cognitive Impairment: Results From the Shelter StudyJournal of the American Medical Directors Association, 2013
- Risk Factors for Adverse Drug Events Among Nursing Home ResidentsArchives of Internal Medicine, 2001